113
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Long-term efficacy and safety of oxycodone–naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study

, , , , &
Pages 1515-1523 | Published online: 19 Apr 2016

References

  • World Health OrganizationCancer Pain Relief2nd edGenevaWorld Health Organization1996
  • NobleMTreadwellJRTregearSJLong-term opioid management for chronic noncancer painCochrane Database Syst Rev20101CD00660520091598
  • American Geriatrics Society Panel on Chronic Pain in Older PersonsThe management of chronic pain in older persons: AGS Panel on chronic pain in older personsJ Am Geriatr Soc19984656356519588381
  • AbdullaAAdamsNBoneMGuidance on the management of pain in older peopleAge Ageing201342Suppl 1i1i5723420266
  • American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older PersonsPharmacological management of persistent pain in older personsJ Am Geriatr Soc20095781331134619573219
  • BlagdenMHaferJDuerrHHoppMBosseBLong-term evaluation of combined prolonged-release oxycodone and naloxone in patients with moderate-to-severe chronic pain: pooled analysis of extension phases of two Phase III trialsNeurogastroenterol Motil201426121792180125346155
  • KahanMSrivastavaAWilsonLMailis-GagnonAMidmerDOpioids for managing chronic non-malignant pain: safe and effective prescribingCan Fam Physician20065291091109617279219
  • PortenoyRKFarrarJTBackonjaMMLong-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry studyClin J Pain200723428729917449988
  • Sandner-KieslingALeyendeckerPHoppMLong-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of non-cancer chronic painInt J Clin Pract201064676377420370845
  • SchulerMGrießingerNOpiode bei nichttumorsch merz im hoheren [Opioids for noncancer pain in the elderly]Schmerz2015294380401 German26264898
  • TrescotAMHelmSHansenHOpioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians’ (ASIPP) GuidelinesPain Physician2008112 SupplS5S6218443640
  • DavisMPSrivastavaMDemographics, assessment and management of pain in the elderlyDrugs Aging2003201235712513114
  • Mundipharma Pharmaceuticals LimitedTargin 5/2.5 mg, 10 mg/5 mg, 20 mg/10 mg and 40/20 mg prolonged release tablets: Summary of Product Characteristics2013 Available from: http://www.medicines.ie/medicine/14383/SPC/Targin+10mg+5mg+and+20mg+10mg+prolonged+release+tabletsAccessed September 15, 2015
  • BurnessCBKeatingGMOxycodone/naloxone prolonged-release: a review of its use in the management of chronic pain while counteracting opioid-induced constipationDrugs201474335337524452879
  • AhmedzaiSHNauckFBar-SelaGBosseBLeyendeckerPHoppMA randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer painPalliat Med2012261506021937568
  • VondrackovaDLeyendeckerPMeissnerWAnalgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic painJ Pain20089121144115418708300
  • AhmedzaiSHLeppertWJaneckiMLong-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer painSupport Care Cancer201523382383025218610
  • CuomoARussoGEspositoGForteCAConnolaMMarcassaCEfficacy and gastrointestinal tolerability of oral oxycodone/naloxone combination for chronic pain in outpatients with cancer: an observational studyAm J Hosp Palliat Care201431886787624249829
  • SchutterUGrunertSMeyerCSchmidtTNolteTInnovative pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: a large observational study under conditions of daily practiceCurr Med Res Opin20102661377138720380506
  • LowensteinOLeyendeckerPHoppMCombined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trialExpert Opin Pharmacother200910453154319243306
  • GuerrieroFSgarlataCMarcassaCRicevutiGRolloneMEfficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patientsClin Interv Aging20151011125565782
  • MagniEBinettiGBianchettiARozziniRTrabucchiMMini-Mental State Examination: a normative study in Italian elderly populationEur J Neurol19963319820221284770
  • RentzAMYuRMuller-LissnerSLeyendeckerPValidation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipationJ Med Econ200912437138319912069
  • FolsteinMFFolsteinSEMcHughPR“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinicianJ Psychiatr Res19751231891981202204
  • MahoneyFIBarthelDWFunctional evaluation: the Barthel indexMd State Med J196514616514258950
  • BonezziCNavaABarbieriMValidazione della versione Italiana del Brief Pain Inventory nei pazienti con dolore cronico [Validation of Italian version Brief Pain Inventory in patients with chronic pain]Minerva Anestesiol2002687–8607611 Italian12244292
  • CleelandCSRyanKMPain assessment: global use of the Brief Pain InventoryAnn Acad Med Singapore19942321291388080219
  • ButlerSFBudmanSHFernandezKCFanciulloGJJamisonRNCross-validation of a screener to predict opioid misuse in chronic pain patients (SOAPP-R)J Addict Med200932667320161199
  • FarrarJTPortenoyRKBerlinJAKinmanJLStromBLDefining the clinically important difference in pain outcome measuresPain200088328729411068116
  • SkaperSDGiustiPFacciLMicroglia and mast cells: two tracks on the road to neuroinflammationFASEB J20122683103311722516295
  • EdwardsRRFillingimRBNessTJAge-related differences in endogenous pain modulation: a comparison of diffuse noxious inhibitory controls in healthy older and younger adultsPain20031011–215516512507710
  • NaugleKMCruz-AlmeidaYFillingimRBRileyJL3rdOffset analgesia is reduced in older adultsPain2013154112381238723872117
  • RileyJL3rdKingCDWongFFillingimRBMauderliAPLack of endogenous modulation and reduced decay of prolonged heat pain in older adultsPain2010150115316020546997
  • WashingtonLLGibsonSJHelmeRDAge-related differences in the endogenous analgesic response to repeated cold water immersion in human volunteersPain2000891899611113297
  • American College of Rheumatology Subcommittee on Osteoarthritis GuidelinesRecommendations for the medical management of osteoarthritis of the hip and knee: 2000 updateArthritis Rheum20004391905191511014340
  • HochbergMCAltmanRDBrandtKDGuidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of RheumatologyArthritis Rheum19953811153515407488272
  • SchnitzerTJAmerican College of RheumatologyUpdate of ACR guidelines for osteoarthritis: role of the coxibsJ Pain Symptom Manage2002234 SupplS24S30 discussion S31–S3411992747
  • MachadoGCMaherCGFerreiraPHEfficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trialsBMJ2015350h122525828856
  • SinghGRecent considerations in nonsteroidal anti-inflammatory drug gastropathyAm J Med19981051B31S38S9715832
  • TrelleSReichenbachSWandelSCardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysisBMJ2011342c708621224324
  • SchnitzerTJManaging chronic pain with tramadol in elderly patientsClin Geriatr199973545
  • LazzariMGrecoMTMarcassaCFinocchiSCaldaruloCCorliOEfficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naive cancer patients: a propensity analysisDrug Des Devel Ther2015958635872
  • TrenkwalderCBenesHGroteLProlonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extensionLancet Neurol201312121141115024140442
  • LandroNIForsEAVapenstadLLHoltheOStilesTCBorchgrevinkPCThe extent of neurocognitive dysfunction in a multidisciplinary pain centre population. Is there a relation between reported and tested neuropsychological functioning?Pain2013154797297723473784
  • SchiltenwolfMAkbarMHugAEvidence of specific cognitive deficits in patients with chronic low back pain under long-term substitution treatment of opioidsPain Physician201417192024452649